• Article highlight
  • Article tables
  • Article images

Article History

Received : 23-01-2024

Accepted : 14-02-2024



Article Metrics




Downlaod Files

   


Article Access statistics

Viewed: 443

PDF Downloaded: 224


Get Permission Chandanwale, Katkar, Katkar, Gaikwad, and Sawalkar: Role of vitamin D in patients with Potts spine


Introduction

Tuberculous spondylodiscitis (Pott spine) is caused by Mycobacterium tuberculosis, a slow growing gram-positive, acid-fast bacillus which becomes lodged in the bone via Batson’s venous plexus and lymphatic from primarily infected lung, lymph nodes, mediastinum and viscera, forming granulomatous inflammation and caseation necrosis.1 It is the most common gorm of skeletal tuberculosis. It is a serious form of extra pulmonary TB which if left untreated can be fatal.2 The treatment of it can be chemotherapy alone or surgery in addition to chemotherapy.

Thoracolumbar region is the most commonly affected site while the cervical and sacrum regions are less commonly involved. Usually more than one vertebra is affected because of its segmental arterial distribution and subligamentous spread of the disease. The bacilli reach the disc space causing disc destruction, spreads to adjacent vertebral bodies leading to vertebral collapse, anterior wedging, characteristic kyphotic angulation (Gibbus deformity), which may compress the spinal cord and nerve roots producing functional impairment.1, 3, 4

Magnetic resonance imaging (MRI) makes the early diagnosis of spinal TB easier and a considerable number of patients with spinal TB are diagnosed earlier and treated more effectively before significant neurological deficits develop. However, patients can still present late with considerable spine deformity.5 IL-1 plays many different roles, from mediating the immune response to infection6 to regulating vascular permeability and angiogenesis.7 Deregulated IL-1 responses have been associated with the development and progression of cancer8 and also with autoimmune diseases such as rheumatoid arthritis.9 But there is paucity of studies evaluating the relationship of pots spine and vitamin D, hence we have undertaken this study with the aim to assess the relationship between Vitamin D levels in patient with Potts spine.

Objectives

To estimate the serum vitamin D level in patients with Potts spine & determine its relationship with Pott’s spine.

Materials and Methods

This was a facility based cross-sectional observational study, protocol of which was approved by the Institutional Ethical committee of the medical college and is consistent with all the ethical standards. Written informed consent was taken from all study subjects.

Patients with back pain with features of Pott's spine such as pain, numbness, loss of sensation, loss of power, loss of tone or bowel/bladder involvement & willing to participate in the study were included. All consecutive patients fulfilling inclusion and exclusion criteria were taken up for the study until the required sample size was fulfilled. Sampling method used was universal. Study was carried out over a period of 2 years from December 2020 to December 2022. Exclusion criteria were Patients with diagnosed neurological dysfunction such as stroke leading to monoparesis/monoplegia/paraparesis/paraplegia/quadriparesis /quadriplegia, peripheral neuropathies, Guillain-barre syndrome or ataxia. Patients with traumatic cervical spine injury, patients with congenital spine deformities, spinal tumours, patients with fractures in upper limb and known psychological dysfunction.

Detailed history regarding onset and progression of symptoms, history of trauma was taken. Detail neurological examination was done following which X-ray lumbar spine AP and

LATERAL view and MRI spine with whole spine screening was carried out. Degree of the spinal cord compression was classified into one off our groups:

Level 0 – no pressure on thecal sac

Level 1 – mild compression on thecal sac

Level 2 – the degree of thecal sac compression is <1/3 Level 3 – the degree of thecal sac compression is >1/3

Then all the patients were subjected to lab investigations such as vitamin D levels  

[normal range: 30-100ng/mL], CBC, RFTs, LFTs, Sr. electrolytes. Results of vitamin D levels were compared statistically with severity of neurological impairment.

Pozo et al10 in their study titled, the course of spinal tuberculosis (Pott disease): results of the multinational, multicentre Backbone-2 study, found that the most common presenting feature amongst spinal TB cases was paraspinal abscesses in 69%, considering this proportion, at 95% confidence interval and 15% allowable error, the sample size came out to be 37. Sample size was calculated with the formula n = [DEFF*Np(1-p ]/ [(d2/Z21- α/2*(N-1 +p*(1-p)], using Epi info version 3.0.

Data was collected in pre-structured proforma which was pilot tested and after ensuring it’s validity. Quantitative data was then tested by Mean and Standard Deviation, difference between more than two means tested by ’ANOVA’ test. P value <0.05 was considered significant.

Results

In the present longitudinal observational study, we have initially planned to include 35 cases of degeneration of intervertebral disc leading to disc bulge /protrusion /extrusion. Total such 35 cases presented, included in the study, and we could analyse all of them giving the response rate of 100%, important observations and results of which are presented below.

Table 1

Distribution of cases according to age groups

Age group  (years)

Cases

No. 

Percentage (%)

<20

05

11.36

21-30

07

15.91

31-40

07

15.91

41-50

14

31.82

51-60

07

15.91

>60

04

9.09

Total

44

100

Mean + S.D.

41.8 + 13.9 years.

In the present study, majority 14 (31.82%) of the cases were from the age group of 41-50 years followed by 07 (15.91%) from the age group of 21-30, 31-40 & 51-60 years age group each, 05 (11.36%) from <20 years and least i.e. 04 (9.09%) from the age group of >60 years. Mean age of the patients was 22.34 + 12.88 years.(Table 1)

Table 2

Distribution of cases according to gender

Gender

Cases

No. 

Percentage (%)

Male

20

45.45

Female 

24

54.55

Total

44

100

In the present study, majority i.e. 24 (54.55%) of the cases were of male gender and only 20 (45.45%) were females.(Table 2)

Figure 1

Gender wise distribution of cases

https://s3-us-west-2.amazonaws.com/typeset-prod-media-server/ebd9dfb4-8f70-47fe-914d-f1c16132ff4bimage2.png

Table 3

Distribution of patients according to laterality

Laterality

Frequency

Percent

Left 

06

13.64

Right 

03

6.81

Bilateral

35

79.55

Total

44

100

In the present study, in most i.e. 35 (79.55%) of the cases affected side  was bilateral followed by left side in 06 (13.64%) and right in 03 (6.81%).(Table 3)

Figure 2

Laterality wise distribution of right cases

https://s3-us-west-2.amazonaws.com/typeset-prod-media-server/ebd9dfb4-8f70-47fe-914d-f1c16132ff4bimage3.png

Majority of the cases had side affected was bilateral.

Table 4

Distribution of patients according to presenting complaints. (n=44)

Presenting complaints

Frequency

Percent

Bowel Bladder Involvement

15

34.09

Hip pain

01

2.27

Motor Power loss/weakness

36

81.82

Neck spasm

01

2.27

Sensory involvement

17

38.64

Severe back pain

43

97.73

Shoulder pain

01

2.27

In the present study, most common presenting complaint was severe back pain in 43 (97.73%) of the cases followed by motor power loss/weakness in 36 (81.82%), sensory involvement in 17 (38.64%), bowel bladder involvement in 15 (34.09%) and shoulder pain, hip pain, neck spasm in one (2.27%) case each. (Table 4)

Table 5

Distribution of patients according to duration of symptoms

Duration of symptoms (months)

Frequency

Percent

<6

27

61.36

>6

17

38.64

Total

44

100

In the present study, among most i.e. 27 (61.36%) of the cases duration of symptoms was <6 months and >6 months among 17 (38.64%).

Table 6

Distribution of patients according to MRI findings. (n=44)

MRI findings

Frequency

Percent

Cervical compression

02

4.55

Thoracic compression

29

65.91

Lumbar compression

23

52.27

Sacral compression

01

2.27

Psoas Abscess

11

25

Tuberculoma

01

2.27

In the present study, among majority i.e. 29 (65.91%) of the cases MRI finding was thoracic compression followed by 23 (52.27%) had lumbar compression, 11 (25%) had psoas abscess, 02 (4.55%) had cervical compression and 1 (2.27%) had sacral compression, tuberculoma each.(Table 6

Table 7

Distribution of patients according to MRI findings indicating degree of spinal cord compression

Degree of spinal cord compression

Frequency

Percent

Level 1

20

45.46

Level 2

12

27.27

Level 3

12

27.27

Total

44

100

In the present study, majority i.e. 20 (45.46%) of the cases had level 1 spinal cord compression followed by 12 (27.27%) had level 2 & level 3 spinal cord compression.(Table 7)

Figure 3

MRI findings amongst cases.

https://s3-us-west-2.amazonaws.com/typeset-prod-media-server/ebd9dfb4-8f70-47fe-914d-f1c16132ff4bimage4.png

Most common finding was extrusion of the disc followed by protrusion of the disc.

Table 8

Distribution of patients according to diagnosis

Diagnosis

Frequency

Percent

Cervical Pott’s spine with disseminated TB

02

4.55

Thoracic Pott’s spine

20

45.46

Thoracic Pott’s spine with psoas abscess

04

9.09

Thoracic Pott’s spine with tuberculoma

01

2.27

Thoracic Pott’s spine with TB meningitis

01

2.27

Thoracic Pott’s spine with paraplegia

03

6.82

 Lumbar Pott’s spine 

15

34.09

Lumbar Pott’s spine with psoas abscess

07

15.91

Lumbar Pott’s spine TB meningitis

01

2.27

Sacral Pott’s spine

01

2.27

In the present study, most common diagnosis was thoracic Pott’s spine among 20 (45.46%) cases followed by lumbar Pott’s spine in 15 (34.09%) cases, lumbar Pott’s spine with psoas abscess in 07 (15.91%), thoracic Pott’s spine with psoas abscess in 04 (9.09%), thoracic Pott’s spine with paraplegia in 03 (6.82%), cervical Pott’s spine with disseminated TB in 02 (4.55%) and thoracic Pott’s spine with tuberculoma, meningitis, lumbar Pott’sspine TB meningitis, sacral Pott’s spine in 1 (2.27%) case each.(Table 8)

Figure 4

Diagnosis wise distribution of cases

https://s3-us-west-2.amazonaws.com/typeset-prod-media-server/ebd9dfb4-8f70-47fe-914d-f1c16132ff4bimage5.png

Most of the cases had intervertebral disc prolapse at L5S1 followed by IVDP at L3L4 level. 

Table 9

Distribution of patients according to serum level of vitamin D

Sr. Level of Vitamin D.

Frequency

Percent

>30 (optimal)

16

36.36

20-30 (insufficient)

12

27.28

<20 (Deficient)

16

36.36

Total

44

100

Mean + SD

25.31 + 11.82

In the present study, serum vitamin D level was optimal (>30 ng/ml) in 16 (36.36%) cases, deficient (<20 ng/ml) in 16 (36.36%) cases and insufficient (20-30 ng/ml) among 12 (27.28%) of the cases.(Table 9)

Figure 5

Level of transforaminal block among cases 

https://s3-us-west-2.amazonaws.com/typeset-prod-media-server/ebd9dfb4-8f70-47fe-914d-f1c16132ff4bimage6.png

Most of the cases were given transforaminal block at S1 level followed by L5S1 & L4 level. 

Table 10

Association of age and serum level of vitamin D in patients with Pott’s spine

Age

Sr. Level of Vitamin D.

P

>30  (optimal)  No. (%)

20-30  (insufficient)  No. (%)

<20  (Deficient)  No. (%)

<20

01 (6.25)

02 (16.67)

02 (12.5)

0.8

21-30

03 (18.75)

02 (16.67)

02 (12.5)

1

31-40

04 (25)

02 (16.67)

01 (6.25)

0.3

41-50

05 (31.25)

01 (8.33)

08 (50)

0.05

51-60

02 (12.5)

04 (33.33)

01 (6.25)

0.19

>60

01 (6.25)

01 (8.33)

02 (12.5)

1

Total

16 (100)

12 (100)

16 (100)

--

In the present study, serum vitamin D level did not differ according to age. So, it was not associated with age group of cases (p>0.05).

Table 11

Association of gender and serum level of vitamin D in patients with Pott’s spine

Gender

Sr. Level of Vitamin D

p

>30 (optimal) (n=16)

20-30 (insufficient) (n=12)

<20 (Deficient) (n=16)

Male

07 (43.75)

07 (58.33)

06 (37.5)

0.6

Female

09 (56.25)

05 (41.67)

10 (62.5)

Total

16 (100)

12 (100)

16 (100)

In the present study, serum vitamin D level did not differ according to gender. Hence, it was not associated with gender of cases (p>0.05).(Table 11)

Table 12

Association of clinical features with the serum level of vitamin D in patients with Pott’s spine

Clinical features

Sr. Level of Vitamin D.

P

>30  (optimal) (n=16) No. (%)

20-30 (insufficient) (n=12) No. (%)

<20  (Deficient) (n=16) No. (%)

Bowel Bladder Involvement

02 (12.5)

04 (33.33)

09 (56.25)

0.03

Hip pain

00 (00)

01 (8.33)

00 (00)

0.2

Motor Power loss/weakness

13 (81.25)

10 (83.33)

13 (81.25)

1

Neck spasm

00 (00)

00 (00)

01 (6.25)

1

Sensory involvement

03 (18.75)

04 (33.33)

10 (62.5)

0.04

Severe Back pain

16 (100)

12 (100)

15 (93.75)

1

Shoulder pain

00 (00)

00 (00)

01 (6.25)

1

In the present study, serum vitamin D level of <20 (insufficient) was significantly associated with the presenting complaints of bowel bladder involvement & sensory involvement (p>0.05). It means severity of the disease increased as the deficiency of serum vitamin D developed. (Table 12)

Table 13

Association of duration of symptoms with serum level of vitamin D in patients with Pott’s spine

Duration of symptoms

Sr. Level of Vitamin D.

P

>30 (optimal)  No. (%)

20-30 (insufficient)  No. (%)

<20 (Deficient)  No. (%)

<6

10 (62.5)

07 (58.33)

10 (62.5)

1

>6

06 (37.5)

05 (41.67)

06 (37.5)

Total

16 (100)

12 (100)

16 (100)

In the present study, serum vitamin D level did not differ according to duration of symptoms. So, it was not associated with duration of the disease (p>0.05).(Table 13)

Table 14

Association of degree of spinal cord compression with the serum level of vitamin D in patients with Pott’s spine

Degree of spinal cord compression

Sr. Level of Vitamin D.

P

>30 (optimal)

20-30 (insufficient) 

<20 (Deficient) 

Level 1

14 (87.5)

02 (16.67)

04 (25)

<0.001

Level 2

01 (6.25)

08 (66.66)

03 (18.75)

<0.001

Level 3

01 (6.25)

02 (16.67)

09 (56.25)

<0.001

Total

16 (100) 

12 (100)

16 (100)

In the present study, serum vitamin D level of >30 (optimal) was significantly associated with level 1 spinal cord compression, 20-30 (insufficient) with level 2 spinal cord compression and <20 (insufficient) with the level 3 spinal cord compression (p<0.001). It means spinal cord compression & severity of the disease increased as the level of serum vitamin D decreased. (Table 14)

Table 15

Association of diagnosis with the serum level of vitamin D in patients with Pott’s spine

Diagnosis

Sr. Level of Vitamin D.

P

>30 (n=16)

20-30 (n=12) 

<20  (n=16)

Cervical Pott’s spine with disseminated TB

00 (00)

00 (00)

02 (12.5)

0.3

Thoracic Pott’s spine

08 (50)

06 (50)

06 (37.5)

0.7

Thoracic Pott’s spine with psoas abscess

02 (12.5)

01 (8.33)

01 (6.25)

1

Thoracic Pott’s spine with tuberculoma

00 (00)

01 (8.33)

00 (00)

0.2

Thoracic Pott’s spine with TB meningitis

00 (00)

01 (8.33)

00 (00)

0.2

Thoracic Pott’s spine with paraplegia

02 (12.5)

01 (8.33)

00 (00)

0.4

Lumbar Pott’s spine 

06 (37.5)

02 (16.67)

07 (43.75)

0.3

Lumbar Pott’s spine with psoas abscess

02 (12.5)

02 (16.67)

02 (12.5)

1

Lumbar Pott’s spine TB meningitis

00 (00)

01 (8.33)

00 (00)

0.2

Sacral Pott’s spine

00 (00)

00 (00)

01 (6.25)

1

In the present study, serum vitamin D level did not differ according to diagnosis. Most of the vitamin D deficient i.e. <20 ng/ml cases had diagnosis of lumbar Pott’s spine (43.75%) and thoracic Pott’s spine (37.5%) but it did not reach significance (p>0.05). So, vitamin d deficiency was not associated with any particular diagnosis. (Table 15)

Discussion

Present study was prospective observational study, done on 44 cases of Pott’s spine to assess relationship of serum levels of vitamin D, important findings of which are discussed below.

In the present study, majority 14 (31.82%) of the cases were from the advancing age group of 41-50 years with the mean age of the patients was 41.8 + 13.9 years. Most (54.55%) of the cases were of male gender. This is consistent with Weiwei Li et al11 reported mean age of 32.0 ± 9.9 years with male majority (63.56%), Rohan R. Patil et al12 noted mean age of 43 (±16.4) years with male majority (64.9%) & Ching-Yun Weng et al13 who also noted male majority (60.52%).

In the current study, most common presenting complaint was severe back pain (97.73%) followed by motor power loss/weakness in 81.82%, sensory involvement in 38.64%, bowel bladder involvement in 34.09% and shoulder pain, hip pain, neck spasm in 2.27% each. 61.36% cases had duration of symptoms <6 months and 38.64% had >6 months. Most i.e. 79.55% of the cases affected side was bilateral. Similarly, Ching-Yun Weng et al13  noted that back pain (100%) was the most common clinical symptom, followed by weakness (53%) and numbness (26%) with mean duration of symptoms 99 days (<6 months) and Rohan R. Patil et al12 reported that back pain being the most common complaint in 102 (89.5%) Pott’s spine cases, followed by weakness in 38 (34.3%), radicular pain in 26 (22.8%), fever with other constitutional in 10 (8.8%), and sinus/swelling over back/ abdominal pain was present in 4 (3.5%). After neurological evaluation, paraparesis/paraplegia was observed in 52 (45.6%) cases and tetraplegia in 2 (1.7%) cases. Sensory deficit was observed in 10 (10.5%) cases. Bowel/bladder involvement was present in 5 (4.4% cases) with the mean duration of symptoms till medical attention was sought was 4.8 (±6.2) months.

In our study, among majority (65.91%) of the cases MRI finding was thoracic compression followed by lumbar compression in 52.27%, psoas abscess in 25%, cervical compression in 4.55%, sacral compression & tuberculoma in 2.27% each. 45.46% of the cases had level 1 spinal cord compression followed by 27.27% had level 2 & level 3 spinal cord compression each. In this study, most common diagnosis was thoracic Pott’s spine among 45.46% cases followed by lumbar Pott’s spine in 34.09%, lumbar Pott’s spine with psoas abscess in 15.91%, thoracic Pott’s spine with psoas abscess in 9.09%, thoracic Pott’sspine with paraplegia in 6.82%, cervical Pott’s spine with disseminated TB in 4.55% and thoracic Pott’s spine with tuberculoma, meningitis, lumbar Pott’s spine TB meningitis, sacral Pott’s spine in 2.27%) each. Consistently, Ching-Yun Weng et al13 reported that lumbar spine (39%) and the thoracic spine (37%) were the most commonly involved site in Pott’s spine. Ching-Yun Weng et al13  also noted that common imaging findings were disc space involvement, paraspinal abscess & epidural compression. Rohan R. Patil et al12 also reported thoracic spine (39.1%) and the lumbar spine (38.1%) were the most commonly involved site in Pott’s spine and observed psoas abscess, lytic lesions and granulation tissue as common pathology.

In this study, serum vitamin D level was optimal (>30 ng/ml) in 36.36% cases while reduced in 63.64% of which 27.28% cases had insufficient (20-30 ng/ml) level & 16 36.36%) cases had deficient (<20 ng/ml) level. Further, reduced serum vitamin D level was not associated with age, gender, duration of symptoms and diagnosis (p>0.05). Serum vitamin D level of <20 (insufficient) was significantly associated with the presenting complaints of bowel bladder involvement & sensory involvement (p>0.05) i.e. increased in neurological severity. Also, serum vitamin D level of >30 (optimal) was significantly associated with level 1 spinal cord compression, 20-30 (insufficient) with level 2 spinal cord compression and <20 (insufficient) with the level 3 spinal cord compression (p<0.001). It means spinal cord compression & severity of the disease increased as the level of serum vitamin D decreased. This finding is in line with the following authors.

Samah Sidahmed M.S Elsafi et al14 while evaluating relationship of vitamin D in pulmonary TB found that vitamin D levels were significantly reduced among TB cases than controls. Likewise, it’s much lower in females, individuals of 21–40 years old, and patients with high bacillary levels or those infected by Rifampicin resistance strain.

Kiran Belur et al15 in their study observed vitamin D deficiency, vitamin D insufficiency, and optimum vitamin D among 55%, 41%, and 3.89% tuberculosis cases, respectively. 

Vijay Jaimni et al16 noted in their study that serum vitamin D levels were significantly lower (P = 0:012) in the tuberculosis group (19 (7.75, 27.25) ng/dl) as compared to the control group (25 (19.75, 32.00) ng/dl). Out of 50 TB patients, 27 (54%) had vitamin D deficiency, while among healthy controls, only 13 (26%) had vitamin D deficiency. Among vitamin D deficient PTB patients, 44% had 3+/hpf AFB in sputum smear examination. S0, the prevalence of vitamin D deficiency in pulmonary tuberculosis cases is very high. Hypovitaminosis D was associated with more severe clinical symptoms, higher sputum smear positivity, and extensive lesions in chest radiograph among pulmonary tuberculosis patients.

Guohua Wang et al17 in their study found that vitamin D receptor gene (VDR-FokI) polymorphism is the susceptible factor of spinal TB and indicators of the clinical severity.

Manish Pareek et al18 reported that individuals with extrapulmonary TB had lower mean serum 25(OH)D concentration than those with pulmonary TB (11.4 vs 15.2 nmol/L, respectively, p=0.0001). On multivariable analysis, vitamin D deficiency was strongly associated with extrapulmonary TB independently of ethnicity, gender and other factors. Doubling in serum 25(OH)D concentration conferred substantially reduced risk of extrapulmonary disease (OR 0.55, 95% CI 0.41 to 0.73).

David A. Jolliffe et al19 in a meta-analysis of adjunctive vitamin D in tuberculosis treatment analysed 1850 participants in eight studies and found that vitamin D did not influence time to sputum culture conversion overall (adjusted HR 1.06, 95% CI 0.91–1.23), but it had accelerated sputum culture conversion in participants with multidrug-resistant pulmonary TB (adjusted HR 13.44, 95% CI 2.96–60.90); no such effect was seen in those whose isolate was sensitive to rifampicin and/ or isoniazid (adjusted HR 1.02, 95% CI 0.88–1.19; p-value for interaction=0.02). Vitamin D accelerated sputum smear conversion overall (adjusted HR 1.15, 95% CI 1.01–1.31), but did not influence other secondary outcomes. But Gurpreet Kaur Randhawa et al20 in randomized control study from Punjab, India found that vitamin D as adjuvant to ATT does not confer additional benefit to newly diagnosed pulmonary tuberculosis patients and concluded that large multi-centric trials are required to find any benefit of vitamin D supplementation with ATT.

Conclusion

Advancing age (41-50 years) male patients most at risk of Pott’s spine with the mean age of 41.8 + 13.9 years.

  1. Thoracic spine was most commonly involved in Pott’s spine followed by lumbar spine with majority having level 1 compression followed by level 2 and level 3 compression.

  2. Most common diagnosis in our study was thoracic Pott’s spine followed by lumbar Pott’s spine & lumbar Pott’s spine with psoas abscess etc.

  3. In this study, we have found reduced serum vitamin D level in 63.64% cases. Reduced serum levels of vitamin D are associated with increased spinal cord compression & disease severity as suggested by the bowel bladder involvement & sensory involvement at levels <20 ng/ml, level 1 spinal cord compression at optimal (>30 ng/ml) vitamin D level, level 2 spinal cord compression at 20-30 ng/ml (insufficient) and level 3 spinal cord compression at deficient (<20 ng/ml) vitamin D level. So, there is an inverse relationship between the level of vitamin D & severity of disease in Pott’s spine.

Source of Funding

There was no source of funding in our study.

Conflict of Interest

None.

References

1 

MF Holick Vitamin D deficiencyN Engl J Med20076326681

2 

B Prietl G Treiber TR Pieber K Amrein Vitamin D and immune functionNutrients201357250221

3 

S Battault SJ Whiting SL Peltier S Sadrin G Gerber JM Maixent Vitamin D metabolism, functions and needs: From science to health claimsEur J Nutr201352242941

4 

PT Liu S Stenger H Li L Wenzel BH Tan SR Krutzik Toll-like receptor triggering of a vitamin D-mediated human antimicrobial responseScience2006311576817703

5 

RF Chun JS Adams M Hewison Immunomodulation by vitamin D: implications for TBExpert Rev Clin Pharmacol20114558391

6 

M Kreutz R Andreesen SW Krause A Szabo E Ritz H Reichel 1, 25-dihydroxyvitamin D3 production and vitamin D3 receptor expression are developmentally regulated during differentiation of human monocytes into macrophagesBlood199382413007

7 

AF Gombart T Saito HP Koeffler Exaptation of an ancient Alu short interspersed element provides a highly conserved vitamin D-mediated innate immune response in humans and primatesBMC Genomics2009101321

8 

S Rajasekaran RM Kanna AP Shetty Pathophysiology and Treatment of Spinal TuberculosisJBJS Rev2014294

9 

JD Colmenero JD Ruiz-Mesa R Sanjuan-Jimenez B Sobrino P Morata Establishing the diagnosis of tuberculous vertebral osteomyelitisEur Spine J201322Suppl 457986

10 

JSGd Pozo MV Soto J Solera Vertebral osteomyelitis: Long-term disability assessment and prognostic factorsJ Infect200754212934

11 

W Li Z Liu X Xiao Z Xu Z Sun Z Zhang Early surgical intervention for active thoracic spinal tuberculosis patients with paraparesis and paraplegiaBMC Musculoskelet Disord202122213

12 

RR Patil GB Mote AK Wankhede KN Wandile CM Badole C Weng Spinal Tuberculosis and Neurological Deficit : A 10 - Year Study in Rural Tertiary Care Center of Central IndiaJ Orthop Traumatol Rehabil2020141558

13 

CY Weng CY Chi PJ Shih CM Ho PC Lin CH Chou Spinal Tuberculosis in Non-HIV-Infected Patients : 10 Year Experience of a Medical Center in Central TaiwanJ Microbiol Immunol Infect.20104364649

14 

SSMS Elsafi BM Nou AD Abakar H Omer BS Almugadam Vitamin D level and it is association with the severity of pulmonary tuberculosis in patients attended to Kosti Teaching Hospital, SudanAIMS Microbiol2020616474

15 

K Belur P Arunachalam JR Raveendran The Association Between Serum Vitamin D Levels and Serum Cathelicidin Antimicrobial Peptide (CAMP) Levels Among Tuberculosis Patients in Comparison with Control SubjectsJ Pharmacol Pharmacother202213217581

16 

V Jaimni BA Shasty SP Madhyastha GV Shetty RV Acharya R Bekur Association of Vitamin D Deficiency and Newly Diagnosed Pulmonary TuberculosisPulm Med20142021528584110.1155/2021/5285841

17 

G Wanga L Xie J Hu H Lu X Liu Y Cao Osteopontin, Bone Morphogenetic Protein-4, and Vitamin D Receptor Gene Polymorphisms in the Susceptibility and Clinical Severity of Spinal TuberculosisCell Physiol Biochem2017415188193

18 

M Pareek J Innes S Sridhar L Grass D Connell G Woltmann Vitamin D deficiency and TB disease phenotypeThorax20157012117180

19 

DA Jolliffe D Ganmaa C Wejse R Raqib MA Haq N Salahuddin Adjunctive vitamin D in tuberculosis treatment: meta-analysis of individual participant dataEur Respir J20195331802003

20 

GK Randhawa S Jindal J Rai NC Kajal A study of vitamin D supplementation with directly observed treatment short course for Pulmonary TuberculosisInt J Basic Clin Pharmacol201766137785



jats-html.xsl


This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.